Novo Nordisk beats on Wegovy sales, expects slower 2025 growth by Investor News Today February 5, 2025 0 Danish drugmaker Novo Nordisk (NVO) reported fourth quarter and full 12 months 2024 earnings Wednesday, beating Wall Road's expectations and bumping its fill up greater than 3% in pre-market buying ...